Tools and Resources

• Guideline
• Guideline Summary
• Opioid Use Disorder Primary Care Pathway and Buprenorphine/Naloxone Induction Flow Diagram
• Prescription Opioid Misuse Index (POMI)
• Guideline videos and webinars:
• • OUD Guideline Summary Video
  • OATrageously Rewarding Medicine – Treating OUD in Primary Care Webcast (from PEIP 2019)
  • CFPC Clinical Webinar: Managing Opioid Use Disorder in Primary Care (PEER Guideline Overview)
  • CFPC Clinical Webinar: An Office Base Induction of Buprenorphine/Naloxone using PEER Guideline

Tools for Assessing Withdrawal

• Clinical Opiate Withdrawal Scale (COWS)
• Subjective Opiate Withdrawal Scale (SOWS)

AMA ACTT Opioid Process Improvement Change Package

• Opioid Process Improvement Change Package
• Opioid Processes Change Package Summary
• Opioid Change Package Self-Directed Course

AHS Harm Reduction and Recovery Module for Primary Care

• Harm Reduction and Recovery Module for Primary Care

Peer Simplified Decision Aid: Osteoarthritis Treatment Options in Primary Care

• Decision Aid: Osteoarthritis Treatment Options
• Umbrella Systematic Review: Managing Osteoarthritis in Primary Care

Tools for Practice

• Location, Location, Location: Treating patients with opioid disorder in primary care
• Does this patient taking prescription opioids have opioid use disorder?
• Buprenorphine-Naloxone for Pharmaceutical Opioid Use Disorder
• What is the Incidence of Iatrogenic Opioid Use Disorder?
• Spread the Word: Widespread Distribution of Naloxone to Decrease Opioid-Related Deaths

Best Science (Bs) Medicine Podcasts

• Episode 404: Does your patient have an opioid use disorder?
• Episode 405: Buprenorphine-naloxone for pharmaceutical opioid use disorder
• Episode 406: How well is opioid agonist therapy managed in primary care?

Comparing Treatment Options for Pain (C-TOP)

• Comparing Treatment Options for Pain (C-TOP)

Mothering and Opioids: Addressing Stigma – Acting Collaboratively Toolkit

• Toolkit
• Webinar

Patient Resources

Patient Resources and Engaging Individuals with Lived Experiences

• Opioid Patient Resources

Choosing Wisely Canada – Opioid Wisely

• Opioid Wisely
• Recommendations for Family Medicine

Other Resources and Tools

• AMA Section of Family Medicine Substance Use Disorder Toolbox of Fee Codes
• CPSA Announcement on Prescribing Changes for Buprenorphine/Naloxone
• • CPSA Announcement
  • ACFP eNews
• Shared Zone Tools
• Alberta Opioid Reports
• • Opioid Surveillance Quarterly Reports
  • Opioid-Related Deaths in Alberta: Review of Medical Examiner Data Report

Other Guidelines and Toolkits

• CRISM National Guideline for the Clinical Management of Opioid Use Disorder
• CAMH Buprenorphine/Naloxone for Opioid Dependence: Clinical Practice Guideline
• CMAJ National Injectable Opioid Agonist Treatment for Opioid Use Disorder Clinical Guideline
  • Note: iOAT falls under the CPSA Standard of Practice: Safe Prescribing for Opioid Use Disorder and requires CPSA approval to initiate
  • A Guideline for the Clinical Management of Opioid Use Disorder
  • Guidance for Injectable Opioid Agonist Treatment for Opioid Use Disorder
  • Treatment of Opioid Use Disorder During Pregnancy – Guideline Supplement
  • Treatment of Opioid Use Disorder for Youth – Guideline Supplement
  • C Centre for Substance Use Guidelines
    • McMaster – Safe and Effective Use of Opioids for Non-Cancer Pain – Practice Toolkit
  • FPC 2017 Canadian Guideline for Opioids for Chronic Non-Cancer Pain
• CFPC Best Advice Guide on Recovery-Oriented Mental Health and Addictions Care in Patient’s Medical Home